These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 36230957)

  • 1. Populations of Tau Conformers Drive Prion-like Strain Effects in Alzheimer's Disease and Related Dementias.
    Hromadkova L; Siddiqi MK; Liu H; Safar JG
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion-like Spreading in Tauopathies.
    Ayers JI; Giasson BI; Borchelt DR
    Biol Psychiatry; 2018 Feb; 83(4):337-346. PubMed ID: 28506438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion-like strain effects in tauopathies.
    Han ZZ; Kang SG; Arce L; Westaway D
    Cell Tissue Res; 2023 Apr; 392(1):179-199. PubMed ID: 35460367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Our Molecular and Mechanistic Understanding of Misfolded Cellular Proteins in Alzheimer's Disease (AD) and Prion Disease (PrD).
    Lukiw WJ
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation.
    Daude N; Kim C; Kang SG; Eskandari-Sedighi G; Haldiman T; Yang J; Fleck SC; Gomez-Cardona E; Han ZZ; Borrego-Ecija S; Wohlgemuth S; Julien O; Wille H; Molina-Porcel L; Gelpi E; Safar JG; Westaway D
    Acta Neuropathol; 2020 Jun; 139(6):1045-1070. PubMed ID: 32219515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prion-Like Behavior of Assembled Tau in Transgenic Mice.
    Clavaguera F; Tolnay M; Goedert M
    Cold Spring Harb Perspect Med; 2017 Oct; 7(10):. PubMed ID: 27940600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease brain contains tau fractions with differential prion-like activities.
    Li L; Shi R; Gu J; Tung YC; Zhou Y; Zhou D; Wu R; Chu D; Jin N; Deng K; Xu J; Gong CX; Iqbal K; Liu F
    Acta Neuropathol Commun; 2021 Feb; 9(1):28. PubMed ID: 33597014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.
    Hasegawa M
    Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease.
    Cohen M; Appleby B; Safar JG
    Prion; 2016; 10(1):9-17. PubMed ID: 26809345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of Tau Filament Fragmentation Provides Insights into Prion-like Spreading.
    Kundel F; Hong L; Falcon B; McEwan WA; Michaels TCT; Meisl G; Esteras N; Abramov AY; Knowles TJP; Goedert M; Klenerman D
    ACS Chem Neurosci; 2018 Jun; 9(6):1276-1282. PubMed ID: 29590529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of yeast to studying amyloid and prion diseases.
    Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
    Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology.
    Wiersma VI; van Hecke W; Scheper W; van Osch MA; Hermsen WJ; Rozemuller AJ; Hoozemans JJ
    Acta Neuropathol Commun; 2016 Oct; 4(1):113. PubMed ID: 27793194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-seeding of Alzheimer-related tau protein by a yeast prion.
    Flach M; Leu C; Martinisi A; Skachokova Z; Frank S; Tolnay M; Stahlberg H; Winkler DT
    Alzheimers Dement; 2022 Dec; 18(12):2481-2492. PubMed ID: 35142027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a Mechanistic Model of Tau-Mediated Pathology in Tauopathies: What Can We Learn from Cell-Based In Vitro Assays?
    Sala-Jarque J; Zimkowska K; Ávila J; Ferrer I; Del Río JA
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain.
    Aoyagi A; Condello C; Stöhr J; Yue W; Rivera BM; Lee JC; Woerman AL; Halliday G; van Duinen S; Ingelsson M; Lannfelt L; Graff C; Bird TD; Keene CD; Seeley WW; DeGrado WF; Prusiner SB
    Sci Transl Med; 2019 May; 11(490):. PubMed ID: 31043574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau proteinopathies and the prion concept.
    Goedert M
    Prog Mol Biol Transl Sci; 2020; 175():239-259. PubMed ID: 32958235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau Prion-Like Propagation: State of the Art and Current Challenges.
    Dujardin S; Hyman BT
    Adv Exp Med Biol; 2019; 1184():305-325. PubMed ID: 32096046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau Lysine Pseudomethylation Regulates Microtubule Binding and Enhances Prion-like Tau Aggregation.
    Xia Y; Bell BM; Giasson BI
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
    Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
    J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.